Nanjing Pharmaceutical (600713.SH) issued 16.059 million restricted stocks for the first time to 173 incentive recipients.

16:35 09/05/2025

Nanjing Pharmaceutical (600713.SH) released an announcement that the company has approved the "Restrictive Measures for the Company in 2025..."

Nanjing Pharmaceutical (600713.SH) announced that the company has approved the proposal "Regarding the Initial Grant of Restricted Stock to the Participants of the Company's 2025 Restricted Stock Incentive Plan." Due to the conditions for granting set out in the 2025 Restricted Stock Incentive Plan being achieved, the company has agreed to grant 16.059 million shares of restricted stock to 173 incentive recipients at a price of 2.46 yuan per share on May 9, 2025.

New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.